Literature DB >> 31840619

A simple cut-off for waist-to-height ratio (0·5) can act as an indicator for cardiometabolic risk: recent data from adults in the Health Survey for England.

Sigrid Gibson1, Margaret Ashwell2,3.   

Abstract

The National Institute for Health and Care Excellence (NICE) has acknowledged the value of waist-to-height ratio (WHtR) as an indicator for 'early health risk'. We used recent UK data to explore whether classification based on WHtR identifies more adults at cardiometabolic risk than the 'matrix' based on BMI and waist circumference, currently used for screening. Data from the Health Survey for England (4112 adults aged 18+ years) were used to identify cardiometabolic risk, indicated by raised glycated Hb, dyslipidaemia and hypertension. HbA1c, total/HDL-cholesterol and systolic blood pressure (BP) were more strongly associated with WHtR than the 'matrix'. In logistic regression models for HbA1c ≥ 48 mmol/mol, total/HDL-cholesterol > 4 and hypertension (BP > 140/90 mmHg or on medication), WHtR had a higher predictive value than the 'matrix'. AUC was significantly greater for WHtR than the 'matrix' for raised HbA1c and hypertension. Of adults with raised HbA1c, 15 % would be judged as 'no increased risk' using the 'matrix' in contrast to 3 % using WHtR < 0·5. For hypertension, comparative values were 23 and 9 %, and for total/HDL-cholesterol > 4, 26 and 13 %. Nearly one-third of the 'no increased risk' group in the 'matrix' had WHtR ≥ 0·5 and hence could be underdiagnosed for cardiometabolic risk. WHtR has the potential to be a better indicator of cardiometabolic risks associated with central obesity than the current NICE 'matrix'. The cut-off WHtR 0·5 in early screening translates to a simple message, 'your waist should be less than half your height', that allows individuals to be aware of their health risks.

Entities:  

Keywords:  BMI; Cardiometabolic risk; National Institute for Health and Care Excellence; Obesity; Waist-to-height ratio

Mesh:

Substances:

Year:  2019        PMID: 31840619     DOI: 10.1017/S0007114519003301

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

1.  Does inflammation mediate the association between obesity and hearing status in mid-childhood and mid-life?

Authors:  Jing Wang; Mengjiao Liu; Valerie Sung; Anneke Grobler; Richard Saffery; Katherine Lange; David Burgner; Melissa Wake
Journal:  Int J Obes (Lond)       Date:  2022-02-26       Impact factor: 5.551

2.  Association of short stature and obesity with cardio-metabolic risk factors in Iranian children and adolescents: the CASPIAN-V study.

Authors:  Omid Safari; Hanieh-Sadat Ejtahed; Nazli Namazi; Ramin Heshmat; Reza Arjmand; Shahrokh Karbalahi Saleh; Ehsan Seif; Armindokht Shahsanai; Mohammad Esmaeil Motlagh; Mohammad Esmaeili Abdar; Mostafa Qorbani; Roya Kelishadi
Journal:  J Diabetes Metab Disord       Date:  2021-06-17

3.  Profiling of Insulin-Like Growth Factor Binding Proteins (IGFBPs) in Obesity and Their Association With Ox-LDL and Hs-CRP in Adolescents.

Authors:  Abdur Rahman; Maha M Hammad; Irina Al Khairi; Preethi Cherian; Reem Al-Sabah; Fahd Al-Mulla; Mohamed Abu-Farha; Jehad Abubaker
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-28       Impact factor: 5.555

4.  Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers.

Authors:  Carla Busquets-Cortés; Carlos López; Hernán Paublini; Sebastiana Arroyo Bote; Ángel Arturo López-González; José Ignacio Ramírez-Manent
Journal:  J Nutr Metab       Date:  2022-08-09

5.  The Association between Peptide Hormones with Obesity and Insulin Resistance Markers in Lean and Obese Individuals in the United Arab Emirates.

Authors:  Manal Ali Ahmad; Mirey Karavetian; Carole Ayoub Moubareck; Gabi Wazz; Tarek Mahdy; Koen Venema
Journal:  Nutrients       Date:  2022-03-17       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.